Evidence map›Paper›PMID 25198338›Full record

ArticlePloS one2014

Functional short tandem repeat polymorphism of PTPN11 and susceptibility to hepatocellular carcinoma in Chinese populations.

Xiankun Zhao, Shuxiang Hu, Lu Wang, Qing Zhang, Xiaodan Zhu, Hua Zhao, Chaoqun Wang, Ruiyang Tao, Siping Guo, Jing Wang and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Functional STR withinInternational journal of clinical and experimental pathology · 2017
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Xiankun ZhaoDepartment of Forensic Medicine, Medical College of Soochow University, Suzhou, Jiangsu, P.R. China.
Shuxiang HuDepartment of Forensic Medicine, Medical College of Soochow University, Suzhou, Jiangsu, P.R. China.
Lu WangDepartment of Forensic Medicine, Medical College of Soochow University, Suzhou, Jiangsu, P.R. China.
Qing ZhangDepartment of Forensic Medicine, Medical College of Soochow University, Suzhou, Jiangsu, P.R. China.
Xiaodan ZhuDepartment of Forensic Medicine, Medical College of Soochow University, Suzhou, Jiangsu, P.R. China.
Hua ZhaoDepartment of General Surgery, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, P.R. China.
Chaoqun WangDepartment of Forensic Medicine, Medical College of Soochow University, Suzhou, Jiangsu, P.R. China.
Ruiyang TaoDepartment of Forensic Medicine, Medical College of Soochow University, Suzhou, Jiangsu, P.R. China.
Siping GuoDepartment of Forensic Medicine, Medical College of Soochow University, Suzhou, Jiangsu, P.R. China.
Jing WangDepartment of Forensic Medicine, Medical College of Soochow University, Suzhou, Jiangsu, P.R. China.
Jiejie XuKey Laboratory of Medical Molecular Virology, MOE & MOH, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
Yan HeDepartment of Epidemiology, Medical College of Soochow University, Suzhou, Jiangsu, P. R. China.
Yuzhen GaoDepartment of Forensic Medicine, Medical College of Soochow University, Suzhou, Jiangsu, P.R. China.
Soochow University · CNFirst Affiliated Hospital of Soochow University · CNShanghai Medical College of Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPTPN11, which encodes tyrosine phosphatase Shp2, is a critical gene mediating cellular responses to hormones and cytokines. Loss of Shp2 promotes hepatocellular carcinoma (HCC), suggesting that PTPN11 functions as a tumor suppressor in HCC tumorgenesis. The aim of this study was to evaluate the effects of the short tandem repeat (STR) polymorphism (rs199618935) within 3'UTR of PTPN11 on HCC susceptibility in Chinese populations. METHODOLOGY/PRINCIPAL

findingsWe analyzed the associations in 400 patients from Jiangsu province of China, validating the findings in an additional 305 patients from Shanghai of China. Unconditional logistic regression was used to analyze the association between rs199618935 and HCC risk. Additional biochemical investigations and in-silico studies were used to evaluate the possible functional significance of this polymorphism. Logistic regression analysis showed that compared with individuals carrying shorter alleles (11 and 12 repeats), those subjects who carry longer alleles (13 and 14 repeats) had a significantly decreased risk of HCC [adjusted odds ratio (OR) = 0.63, 95% confidence interval (CI)  = 0.53-0.76, P = 2.00 × 10(-7)], with the risk decreased even further in those carrying allele 15 and 16 (adjusted OR = 0.46, 95% CI = 0.34-0.62, P = 1.00 × 10(-7)). Biochemical investigations showed that longer alleles of rs199618935 conferred higher PTPN11 expression in vivo and in vitro. The altered luciferase activities in reporter gene system suggested that STR regulation of PTPN11 expression could be a transcriptional event. Finally, in-silico prediction revealed that different alleles of rs199618935 could alter the local structure of PTPN11 mRNA. CONCLUSIONS/SIGNIFICANCE: Taken together, our findings suggested that the STR polymorphism within PTPN11 contributes to hepatocarcinogenesis, possibly by affecting PTPN11 expression through a structure-dependent mechanism. The replication of our studies and further functional studies are needed to validate our findings.

Indexed as

Genetic Predisposition to DiseaseMicrosatellite RepeatsPolymorphism, GeneticBase SequenceCarcinoma, HepatocellularCase-Control StudiesChinaDNA PrimersHumansLiver NeoplasmsProtein Tyrosine Phosphatase, Non-Receptor Type 11Real-Time Polymerase Chain ReactionDNA PrimersProtein Tyrosine Phosphatase, Non-Receptor Type 11PTPN11 protein, human

Identifiers

PMID25198338
PMCPMC4157842
OpenAlexW1999586687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.